A Study of GDC-0810 Versus Fulvestrant in Postmenopausal Women With Advanced or Metastatic Breast Cancer Resistant to Aromatase Inhibitor (AI) Therapy
Clinical trial NCT02569801 · TERMINATED
Trial details
- NCT number
- NCT02569801
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-04
- Primary completion
- 2020-02-28
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.